According to Celldex Therapeutics's latest financial reports the company's current EPS (TTM) is -2,30ย โฌ. In 2022 the company made an earnings per share (EPS) of -2,29ย โฌ a decrease over its 2021 EPS that were of -1,57ย โฌ.